NasdaqGS:ENTABiotechs
Enanta Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Enanta Pharmaceuticals ( NASDAQ:ENTA ) Second Quarter 2025 Results Key Financial Results Revenue: US$14.9m (down 13...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.